Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366716 · ClinicalTrials.gov registry record · NA
Contingency Management for Cocaine Dependence: Cash Versus Vouchers
A NA study, sponsored by Treatment Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 352
- Enrollment target
NCT01366716 is a NA study that has completed, run by Treatment Research Institute. The registered enrollment target is 352 participants.
The verdict
NCT01366716, a NA study, has completed, sponsored by Treatment Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 352 participants
- Enrollment target
Study Summary
Contingency management (CM) is a demonstrably efficacious intervention for substance abuse and dependence. Although CM protocols have employed a variety of reinforcers, they have almost exclusively relied upon non-cash privileges (e.g., take-home methadone doses), prizes, or vouchers that can be exchanged for goods or services. Despite the strong empirical support for CM, our research suggests that concerns relating to its cost and safety (e.g., potential for harm caused by rewards undermining intrinsic motivation or being sold to purchase drugs) have hindered its transfer to real-world practice. The exclusive use of non-cash CM likely stems from the untested assumption that clients will use cash incentives to buy drugs or engage in other high-risk behaviors. This assumption is problematic for two reasons. First, the use of non-cash incentives may add substantial costs and complexity to CM protocols. Second, the use of non-cash incentives may reduce the efficacy of CM interventions, as research suggests that cash may be a more effective reinforcer than vouchers. This study examines both practical and ethical issues relating to cash-based CM procedures. This study consists of three phases; a main experiment, a "Cash Bowl" pilot, and a "Thinning" Pilot.
Interventions
- BEHAVIORAL Cash CM
- BEHAVIORAL Voucher CM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2008-04 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01366716
The ClinicalTrials.gov registry entry for NCT01366716 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Treatment Research Institute, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cash CM is the first listed.
NCT01366716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01366716 about?
NCT01366716 is a clinical study titled "Contingency Management for Cocaine Dependence: Cash Versus Vouchers". Contingency management (CM) is a demonstrably efficacious intervention for substance abuse and dependence. Although CM protocols have employed a variety of reinforcers, they have almost exclusively relied upon non-cash privileges (e.g., take-home methadone doses), prizes, or vouchers that can be exc...
What is the current status of trial NCT01366716?
This trial is currently completed. It is a NA study. The enrollment target is 352 participants. The study started on 2008-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01366716?
The interventions under investigation include: Cash CM (BEHAVIORAL), Voucher CM (BEHAVIORAL).
Who is sponsoring clinical trial NCT01366716?
This trial is sponsored by Treatment Research Institute, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.